News and Trends 10 Oct 2017 Market Ready HIV Self-Test Gets the Thumbs Up from the European Union Technology allowing individuals to accurately test themselves for HIV has received a CE Mark from the EU, meaning it can soon be released onto the market. The EU has awarded a CE Mark to an HIV self-test, developed by world-leading diagnostics developer, Atomo Diagnostics, Sydney, Australia. The world’s first at-home device detects the presence of Human Immunodeficiency Virus […] October 10, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2017 Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub Italy may not be the first country that comes to mind when you think of biotech, but the sun is rising in a new dawn for Italian biotechs that are taking their respective fields by storm. Italy is home to a lot of things; food, fashion, Ferraris… but it is now quickly growing a biotech scene […] October 10, 2017 - 7 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 10 Oct 2017 Update: Finnish Biotech to Raise £10M for Rare Lung Disease Drug Update (10/10/2017): Faron Pharmaceuticals’ fundraising has been October 10, 2017 - 1 minutemin - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 9 Oct 2017 British Scientists Regenerate Bone By Mimicking Nature Nano-sized vesicles that are generated naturally during bone formation have the potential to regenerate bone, teeth and cartilage. Researchers from the University of Birmingham have mimicked the body’s natural healing process to repair damaged tissue, for example, bone. The study, which is published in Scientific Reports, has found that vesicles produced by stimulated cells outperform the […] October 9, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Interview 9 Oct 2017 The Woman Developing the Next Generation of Cancer Immunotherapy Özlem Türeci discusses the future of individualized cancer therapy and her journey to become an entrepreneur and take science to patients. As a trained physician and immunologist, Dr. Özlem Türeci has led her own research group with Prof. Ugur Sahin at the University of Mainz, Germany, since 2000. But academic research was not enough for her, […] October 9, 2017 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2017 Mind the Gut: Copenhagen Exhibition Explores Bacteria and Feelings The exhibition Mind the Gut at the Medical Museion in Copenhagen opens its doors to visitors to challenge the view of our own bodies. The Medical Museion in Copenhagen has expanded its exhibition area to make way for Mind the Gut, an exploration of the complex relationship between our brain and bowels through art, science, […] October 7, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Oct 2017 Study Reveals No Evidence to Support Most European Cancer Drug Approvals A new study concludes the majority of cancer drugs approved by the EMA between 2009 and 2013 weren’t backed by sufficient evidence that they are effective. A team of researchers from King’s College London and the London School of Economics has published a new study reviewing the clinical data used to back the approval of […] October 6, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Oct 2017 British-Finnish Alliance to Bring Gene Therapy to the Masses FIT Biotech and Avacta hope to combine their technologies to produce highly specific, best-in-class gene therapy treatments. The two companies have spotted an opportunity to bring together their technologies and form a leading gene therapy system in a market that could be worth over $4.3B (€3.7B) by 2024. FIT Biotech, based in Finland, has been working on […] October 6, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2017 Spanish Biotech’s Stock Surges After Decision to Move out of Barcelona Oryzon Genomics announced it will move its headquarters from Barcelona to Madrid days after the Catalonian independence vote, making its stock grow by 30%. Oryzon Genomics, a Spanish biotech leveraging epigenetics to treat cancer, announced on Tuesday its decision to move out of Barcelona and establish its new headquarters in Madrid, citing the “optimization of […] October 5, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2017 British Biotech To Raise £12.2M to Finish Off Liquid Biopsy Technology Angle will raise £12.2M, which will allow it to acquire assets from Axela to put the finishing touches to its full liquid biopsies solution. Angle is a leader in the liquid biopsy market, the ‘holy grail’ of cancer diagnostics. The company has developed technology that recently outperformed the gold standard in the field. Angle is hoping to raise £12.2M […] October 5, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2017 Dutch Clinical Trial Points to Fecal Transplant as Diabetes Treatment A small clinical trial in the Netherlands has found that a fecal transplant from a lean donor can temporarily improve diabetes symptoms in obese men. Research published in Cell Metabolism from the University of Amsterdam has found that a fecal transplant from lean men to obese men can cause a short-term improvement in insulin resistance. This […] October 5, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2017 British Biotech Founder Receives the Nobel Prize in Chemistry 2017 Richard Henderson, awarded the Nobel Prize in Chemistry 2017, founded Heptares Therapeutics to apply his Nobel-winning technology to discover new medicines. This year’s Nobel Prize in Chemistry has been awarded to Jacques Dubochet, Joachim Frank and Richard Henderson for the development of cryo-electron microscopy. This technology, now widely used in structural biology labs, is considered a stepping […] October 5, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email